Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples